BCRX

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

BioCryst Pharmaceuticals Inc

NASDAQ | BCRX

6.72

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 15, 2025)

$1.35B

Market Cap

-

P/E Ratio

-0.18

EPS

$11.31

52 Week High

$6.00

52 Week Low

HEALTHCARE

Sector

BCRX Chart

Recent Chart
Price Action

BCRX Technicals

Tags:

BCRX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $438M
Total Revenue $451M
Cost Of Revenue $12M
Costof Goods And Services Sold $12M
Operating Income -$2.5M
Selling General And Administrative $253M
Research And Development $175M
Operating Expenses $441M
Investment Income Net -
Net Interest Income -$84M
Interest Income $15M
Interest Expense $99M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$87M
Income Tax Expense $1.9M
Interest And Debt Expense -
Net Income From Continuing Operations -$89M
Comprehensive Income Net Of Tax -
Ebit $12M
Ebitda $13M
Net Income -$89M

Revenue & Profitability

Earnings Performance

BCRX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $490M
Total Current Assets $422M
Cash And Cash Equivalents At Carrying Value $105M
Cash And Short Term Investments $105M
Inventory $8.1M
Current Net Receivables $79M
Total Non Current Assets $68M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $20M
Short Term Investments $216M
Other Current Assets $14M
Other Non Current Assets -
Total Liabilities $966M
Total Current Liabilities $160M
Current Accounts Payable $12M
Deferred Revenue -
Current Debt -
Short Term Debt $35M
Total Non Current Liabilities $806M
Capital Lease Obligations $13M
Long Term Debt $796M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $841M
Other Current Liabilities $113M
Other Non Current Liabilities -
Total Shareholder Equity -$476M
Treasury Stock -
Retained Earnings -$1.8B
Common Stock $2.1M
Common Stock Shares Outstanding $207M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$52M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.2M
Capital Expenditures $1.1M
Change In Receivables -
Change In Inventory -$4.2M
Profit Loss -
Cashflow From Investment $53M
Cashflow From Financing -$5.8M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$89M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $438M
Total Revenue $451M
Cost Of Revenue $12M
Costof Goods And Services Sold $12M
Operating Income -$2.5M
Selling General And Administrative $253M
Research And Development $175M
Operating Expenses $441M
Investment Income Net -
Net Interest Income -$84M
Interest Income $15M
Interest Expense $99M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$87M
Income Tax Expense $1.9M
Interest And Debt Expense -
Net Income From Continuing Operations -$89M
Comprehensive Income Net Of Tax -
Ebit $12M
Ebitda $13M
Net Income -$89M

BCRX News

BCRX Profile

BioCryst Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

BioCryst Pharmaceuticals, Inc. is a cutting-edge biotechnology company headquartered in Durham, North Carolina, dedicated to pioneering oral and small molecule therapeutics for rare diseases. The company’s robust pipeline features innovative treatments aimed at addressing significant unmet medical needs, with a particular emphasis on hereditary angioedema and viral infections. BioCryst is recognized for its scientific rigor and nimble approach to drug development, making it an appealing investment for institutional investors looking for growth opportunities in the burgeoning rare disease therapeutic landscape.

VHAI
0.00%
$0.00
GNPX
+206.61%
$0.77
YYAI
-4.53%
$0.14
VIVK
+41.64%
$0.26
CGBS
-39.47%
$0.03
BURU
-20.46%
$0.32
COOT
+248.18%
$3.36
LAES
+24.79%
$7.65
DFLI
+45.84%
$2.23
BITF
+2.56%
$6.04
OMER
+150.24%
$10.26
NVDA
+1.13%
$182.06
TOVX
+34.85%
$0.58
RGTI
-5.66%
$52.93
CAN
+4.72%
$1.88
PLUG
-3.30%
$3.91
AXDX
-61.36%
$0.03
RXRX
+8.23%
$6.37
NVTS
+18.53%
$14.90
NEHC
+30.63%
$3.07
UAMY
+4.54%
$17.47
AMD
+8.12%
$235.81
RR
-6.25%
$6.30
ACHR
+5.79%
$13.77
YDKG
-85.89%
$0.19
PFAI
+69.63%
$3.24
DNN
+0.31%
$3.20
BMNR
-6.91%
$52.92
BYND
+2.66%
$0.80
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
SEED
+42.16%
$2.04
SRM
+53.27%
$10.30
DVLT
-2.51%
$2.13
QBTS
+4.22%
$44.88
ATCH
+8.06%
$0.43
IONZ
+9.37%
$2.81
UUUU
-6.59%
$24.50
SOFI
+2.07%
$28.44
KDLY
-7.78%
$0.78
QUBT
+0.13%
$21.81
QS
+10.05%
$18.57
ADAP
+16.43%
$0.18
MARA
+2.99%
$22.90
TSLA
+1.95%
$437.61
RGTZ
-5.37%
$8.80
ETHD
+5.07%
$3.73
CIFR
+0.23%
$20.94
BULL
-0.08%
$11.73
SMR
+17.04%
$53.59
VERI
+52.19%
$8.31
CRML
-21.02%
$23.67
INTC
+2.68%
$36.58
QSI
+20.93%
$2.60
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BAC
+5.19%
$52.69
SOUN
+0.31%
$20.92
WLGS
-5.57%
$0.04
FHN
-11.59%
$20.35
GPUS
-5.64%
$0.38
ETWO
0.00%
$3.30
NAK
+2.89%
$2.84
REKR
+21.15%
$2.52
TLRY
+0.62%
$1.61
NOK
+1.91%
$5.57
LGO
-40.67%
$1.49
GDXD
-13.09%
$0.66
APLD
+13.29%
$39.70
AFMD
-34.94%
$0.18
CLSK
+3.32%
$22.71
NUAI
+17.92%
$3.62
SANA
+31.68%
$5.86
TMQ
-15.56%
$8.94
SLNH
+36.59%
$3.81
BBD
+1.30%
$3.19
IREN
+1.24%
$70.42
RIG
+3.52%
$3.23
F
+0.25%
$11.67
NAKA
-1.53%
$0.77
AAL
+1.24%
$12.34
OPI
-16.97%
$0.20
AMZN
-0.63%
$215.01
KLG
-9.05%
$13.35
AREC
-22.24%
$5.29
ABAT
-14.78%
$9.65
RKDA
+34.68%
$4.97
UEC
+2.21%
$15.66
GRYP
-10.38%
$1.38
USAR
-9.24%
$34.07
HI
+17.87%
$31.22
MODV
-25.22%
$0.43
WULF
+3.10%
$15.94
WOK
-15.83%
$0.06
TE
+23.42%
$4.94
ONDS
-3.41%
$10.05
ERIC
-2.91%
$9.56
NIO
+0.88%
$6.86
WWR
-22.41%
$2.70
SDOT
+90.17%
$9.86
VHAI
0.00%
$0.00
GNPX
+206.61%
$0.77
YYAI
-4.53%
$0.14
VIVK
+41.64%
$0.26
CGBS
-39.47%
$0.03
BURU
-20.46%
$0.32
COOT
+248.18%
$3.36
LAES
+24.79%
$7.65
DFLI
+45.84%
$2.23
BITF
+2.56%
$6.04
OMER
+150.24%
$10.26
NVDA
+1.13%
$182.06
TOVX
+34.85%
$0.58
RGTI
-5.66%
$52.93
CAN
+4.72%
$1.88
PLUG
-3.30%
$3.91
AXDX
-61.36%
$0.03
RXRX
+8.23%
$6.37
NVTS
+18.53%
$14.90
NEHC
+30.63%
$3.07
UAMY
+4.54%
$17.47
AMD
+8.12%
$235.81
RR
-6.25%
$6.30
ACHR
+5.79%
$13.77
YDKG
-85.89%
$0.19
PFAI
+69.63%
$3.24
DNN
+0.31%
$3.20
BMNR
-6.91%
$52.92
BYND
+2.66%
$0.80
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
SEED
+42.16%
$2.04
SRM
+53.27%
$10.30
DVLT
-2.51%
$2.13
QBTS
+4.22%
$44.88
ATCH
+8.06%
$0.43
IONZ
+9.37%
$2.81
UUUU
-6.59%
$24.50
SOFI
+2.07%
$28.44
KDLY
-7.78%
$0.78
QUBT
+0.13%
$21.81
QS
+10.05%
$18.57
ADAP
+16.43%
$0.18
MARA
+2.99%
$22.90
TSLA
+1.95%
$437.61
RGTZ
-5.37%
$8.80
ETHD
+5.07%
$3.73
CIFR
+0.23%
$20.94
BULL
-0.08%
$11.73
SMR
+17.04%
$53.59
VERI
+52.19%
$8.31
CRML
-21.02%
$23.67
INTC
+2.68%
$36.58
QSI
+20.93%
$2.60
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BAC
+5.19%
$52.69
SOUN
+0.31%
$20.92
WLGS
-5.57%
$0.04
FHN
-11.59%
$20.35
GPUS
-5.64%
$0.38
ETWO
0.00%
$3.30
NAK
+2.89%
$2.84
REKR
+21.15%
$2.52
TLRY
+0.62%
$1.61
NOK
+1.91%
$5.57
LGO
-40.67%
$1.49
GDXD
-13.09%
$0.66
APLD
+13.29%
$39.70
AFMD
-34.94%
$0.18
CLSK
+3.32%
$22.71
NUAI
+17.92%
$3.62
SANA
+31.68%
$5.86
TMQ
-15.56%
$8.94
SLNH
+36.59%
$3.81
BBD
+1.30%
$3.19
IREN
+1.24%
$70.42
RIG
+3.52%
$3.23
F
+0.25%
$11.67
NAKA
-1.53%
$0.77
AAL
+1.24%
$12.34
OPI
-16.97%
$0.20
AMZN
-0.63%
$215.01
KLG
-9.05%
$13.35
AREC
-22.24%
$5.29
ABAT
-14.78%
$9.65
RKDA
+34.68%
$4.97
UEC
+2.21%
$15.66
GRYP
-10.38%
$1.38
USAR
-9.24%
$34.07
HI
+17.87%
$31.22
MODV
-25.22%
$0.43
WULF
+3.10%
$15.94
WOK
-15.83%
$0.06
TE
+23.42%
$4.94
ONDS
-3.41%
$10.05
ERIC
-2.91%
$9.56
NIO
+0.88%
$6.86
WWR
-22.41%
$2.70
SDOT
+90.17%
$9.86
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.